EMulate Therapeutics, Inc. (EMTX)

EMulate Therapeutics Statistics

Total Valuation

EMTX has a market cap or net worth of $69.31 million. The enterprise value is $79.51 million.

Market Cap	69.31M
Enterprise Value	79.51M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

EMTX has 13.86 million shares outstanding.

Shares Outstanding	13.86M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	271.81
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	311.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.33

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$36,429
Profits Per Employee	-$4.00M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EMTX had revenue of $255,000 and -$28.02 million in losses. Loss per share was -$2.02.

Revenue	255,000
Gross Profit	255,000
Operating Income	-15.97M
Pretax Income	-28.02M
Net Income	-28.02M
EBITDA	-23.90M
EBIT	-24.66M
Loss Per Share	-$2.02

Balance Sheet

The company has $10,000 in cash and $10.21 million in debt, giving a net cash position of -$10.20 million or -$0.74 per share.

Cash & Cash Equivalents	10,000
Total Debt	10.21M
Net Cash	-10.20M
Net Cash Per Share	-$0.74
Equity (Book Value)	-23.91M
Book Value Per Share	-1.72
Working Capital	-19.75M

Cash Flow

In the last 12 months, operating cash flow was -$3.87 million and capital expenditures -$7,000, giving a free cash flow of -$3.88 million.

Operating Cash Flow	-3.87M
Capital Expenditures	-7,000
Free Cash Flow	-3.88M
FCF Per Share	-$0.28

Margins

Gross margin is 100.00%, with operating and profit margins of -6,264.31% and -10,989.41%.

Gross Margin	100.00%
Operating Margin	-6,264.31%
Pretax Margin	-10,989.41%
Profit Margin	-10,989.41%
EBITDA Margin	-9,370.59%
EBIT Margin	-9,670.59%
FCF Margin	-1,520.39%

Dividends & Yields

EMTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-40.43%
FCF Yield	-5.59%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1